Boothbay Fund Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-149,035
| Closed | -$213K | – | 1788 |
|
|
2023
Q4 | $213K | Buy |
149,035
+10,122
| +7% | +$14.5K | 0.01% | 1153 |
|
|
2023
Q3 | $203K | Buy |
+138,913
| New | +$203K | ﹤0.01% | 1240 |
|
|
2019
Q2 | – | Sell |
-31,578
| Closed | -$132K | – | 832 |
|
|
2019
Q1 | $132K | Buy |
31,578
+14,058
| +80% | +$58.8K | 0.01% | 539 |
|
|
2018
Q4 | $60K | Buy |
+17,520
| New | +$60K | 0.01% | 503 |
|